{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:04:19Z","timestamp":1782691459349,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.autrev.2016.03.017","type":"journal-article","created":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T18:21:55Z","timestamp":1458670915000},"page":"786-794","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Post-steroid neuropsychiatric manifestations are significantly more frequent in SLE compared with other systemic autoimmune diseases and predict better prognosis compared with de novo neuropsychiatric SLE"],"prefix":"10.1016","volume":"15","author":[{"given":"Yuka","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Hisada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumasa","family":"Ohmura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanae","family":"Shimamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Shida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Fujieda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Oku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Bohgaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Horita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Kusumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Atsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2016.03.017_bb0005","series-title":"DUBOIS' lupus erythematosus and related syndromes","first-page":"1","article-title":"Definition and classification of lupus and lupus-related disorders","author":"Yazdany","year":"2013"},{"key":"10.1016\/j.autrev.2016.03.017_bb0010","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0140-6736(14)60128-8","article-title":"Systemic lupus erythematosus","volume":"384","author":"Lisnevskaia","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2016.03.017_bb0015","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.md.0000091181.93122.55","article-title":"Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients","volume":"82","author":"Cervera","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2016.03.017_bb0020","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1177\/0961203306073133","article-title":"Mortality related to cerebrovascular disease in systemic lupus erythematosus","volume":"15","author":"Bernatsky","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2016.03.017_bb0025","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrrheum.2014.15","article-title":"Diagnosis and management of neuropsychiatric SLE","volume":"10","author":"Hanly","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2016.03.017_bb0030","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"42","author":"ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.03.017_bb0035","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/cpt1972135part1694","article-title":"Acute adverse reactions to prednisone in relation to dosage","volume":"13","author":"Program BCDS","year":"1972","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.autrev.2016.03.017_bb0040","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jama.1950.02920050005002","article-title":"Management of rheumatoid arthritis with smaller (maintenance) doses of cortisone acetate","volume":"144","author":"Boland","year":"1950","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2016.03.017_bb0045","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0165-0327(83)90022-8","article-title":"Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature","volume":"5","author":"Lewis","year":"1983","journal-title":"J Affect Disord"},{"key":"10.1016\/j.autrev.2016.03.017_bb0050","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.03.017_bb0055","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.03.017_bb0060","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2016.03.017_bb0065","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2016.03.017_bb0070","first-page":"424","article-title":"Preliminary criteria for classification of adult Still's disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.03.017_bb0075","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2332\/allergolint.R-07-141","article-title":"ANCA-associated vasculitis: diagnostic and therapeutic strategy","volume":"56","author":"Ozaki","year":"2007","journal-title":"Allergol Int"},{"key":"10.1016\/j.autrev.2016.03.017_bb0080","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/art.1780330805","article-title":"The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa","volume":"33","author":"Lightfoot","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.03.017_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 Revised International Chapel Hill Consensus Conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.03.017_bb0090","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/1529-0131(200110)45:5<419::AID-ART360>3.0.CO;2-X","article-title":"Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation","volume":"45","author":"Ainiala","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.03.017_bb0095","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/art.33340","article-title":"Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events","volume":"64","author":"Otomo","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.03.017_bb0100","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.autrev.2016.03.017_bb0105","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.03.017_bb0110","first-page":"1695","article-title":"Acute central nervous system complications after pulse steroid therapy in patients with systemic lupus erythematosus","volume":"17","author":"Wysenbeek","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.03.017_bb0115","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1007\/s00415-014-7472-y","article-title":"New-onset psychiatric disorders after corticosteroid therapy in systemic lupus erythematosus: an observational case-series study","volume":"261","author":"Nishimura","year":"2014","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2016.03.017_bb0120","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1212\/WNL.61.1.104","article-title":"Factors predictive of corticosteroid psychosis in patients with systemic lupus erythematosus","volume":"61","author":"Chau","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2016.03.017_bb0125","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s00296-013-2750-z","article-title":"Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus","volume":"33","author":"Bhangle","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2016.03.017_bb0130","first-page":"2156","article-title":"Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance","volume":"31","author":"Hanly","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.03.017_bb0135","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/ard.2010.130476","article-title":"EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs","volume":"69","author":"Bertsias","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.03.017_bb0140","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/rheumatology\/keh384","article-title":"Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort","volume":"43","author":"Mikdashi","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2016.03.017_bb0145","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/ard.62.9.859","article-title":"Contribution of the initial features of systemic lupus erythematosus to the clinical evolution and survival of a cohort of Mediterranean patients","volume":"62","author":"Bujan","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.03.017_bb0150","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.autrev.2015.10.003","article-title":"A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus","volume":"15","author":"Ho","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.03.017_bb0155","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrrheum.2010.62","article-title":"Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations","volume":"6","author":"Bertsias","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2016.03.017_bb0160","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.autrev.2014.04.002","article-title":"Neuropsychiatric systemic lupus erythematosus: tools for the diagnosis","volume":"13","author":"Zardi","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.03.017_bb0165","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.semarthrit.2006.11.003","article-title":"Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome","volume":"36","author":"Zandman-Goddard","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.03.017_bb0170","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.psyneuen.2007.12.007","article-title":"Blood\u2013brain barrier damage as a risk factor for corticosteroid-induced psychiatric disorders in systemic lupus erythematosus","volume":"33","author":"Nishimura","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.autrev.2016.03.017_bb0175","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/art.22451","article-title":"Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus","volume":"56","author":"Fragoso-Loyo","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.03.017_bb0180","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1136\/ard.2010.148502","article-title":"Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus","volume":"70","author":"Hanly","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.03.017_bb0185","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s10067-009-1226-8","article-title":"Accuracy of cerebrospinal fluid IL-6 testing for diagnosis of lupus psychosis. A multicenter retrospective study","volume":"28","author":"Hirohata","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2016.03.017_bb0190","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/1529-0131(199801)41:1<41::AID-ART6>3.0.CO;2-7","article-title":"Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease","volume":"41","author":"Kozora","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.03.017_bb0195","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2169\/internalmedicine.38.785","article-title":"Asymptomatic cerebrovascular lesions detected by magnetic resonance imaging in patients with systemic lupus erythematosus lacking a history of neuropsychiatric events","volume":"38","author":"Nomura","year":"1999","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2016.03.017_bb0200","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.autrev.2013.07.004","article-title":"Neuropsychiatric systemic lupus erythematosus: magnetic resonance imaging findings and correlation with clinical and immunological features","volume":"12","author":"Toledano","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.03.017_bb0205","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.autrev.2014.11.001","article-title":"Brain abnormalities in newly diagnosed neuropsychiatric lupus: systematic MRI approach and correlation with clinical and laboratory data in a large multicenter cohort","volume":"14","author":"Sarbu","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.03.017_bb0210","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/rheumatology\/ken260","article-title":"Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease","volume":"47","author":"Pego-Reigosa","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2016.03.017_bb0215","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1749-6632.2009.04980.x","article-title":"Glucocorticoids. mood, memory, and mechanisms","volume":"1179","author":"Wolkowitz","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2016.03.017_bb0220","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.autrev.2014.12.007","article-title":"The importance of glucocorticoid receptors in systemic lupus erythaematosus. A systematic review","volume":"14","author":"Bazso","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.03.017_bb0225","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3109\/08916934.2013.830714","article-title":"Association study of glucocorticoid receptor genetic polymorphisms with efficacy of glucocorticoids in systemic lupus erythematosus: a prospective cohort study","volume":"46","author":"Zou","year":"2013","journal-title":"Autoimmunity"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721630074X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721630074X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T04:54:13Z","timestamp":1536900853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899721630074X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S156899721630074X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2016.03.017","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-steroid neuropsychiatric manifestations are significantly more frequent in SLE compared with other systemic autoimmune diseases and predict better prognosis compared with de novo neuropsychiatric SLE","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2016.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}